<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="142952">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01945684</url>
  </required_header>
  <id_info>
    <org_study_id>DW_DWP450002</org_study_id>
    <nct_id>NCT01945684</nct_id>
  </id_info>
  <brief_title>A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Daewoong Pharmaceutical Co. LTD.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Daewoong Pharmaceutical Co. LTD.</source>
  <oversight_info>
    <authority>Korea: Ministry of Food and Drug Safety</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: This study is a Randomized, Double Blind, Multi-center, Active Drug Controlled,
      Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in
      Treatment of Post Stroke Upper Limb(wrist, finger, elbow, thumb)Spasticity.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>N/A</study_design>
  <primary_outcome>
    <measure>The change in MAS(Modified Ashworth Scale)grade for Wrist flexor</measure>
    <time_frame>at 4 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>The change in MAS (Modified Ashworth Scale) grade from baseline at week 4 for wrist flexor muscle tone</description>
  </primary_outcome>
  <condition>Post Stroke Upper Limb Spasticity</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botulinum toxin type A</intervention_name>
    <description>Maximum dose 360 U</description>
    <other_name>Assigned Interventions</other_name>
    <other_name>Experimental: DWP450</other_name>
    <other_name>Botulinum toxin type A Drug: Botulinum toxin type A</other_name>
    <other_name>Active Comparator: Botox®</other_name>
    <other_name>Botulinum Toxin type A Drug: Botulinum Toxin type A (Botox®)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female adult patients

          2. ≥ 6 weeks since the last stroke

        Exclusion Criteria:

        1.Patients with diagnosed neuromuscular disorders such as Lamber-Eaton syndrome,
        myasthenia gravis, or amyotrophic lateral sclerosis.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>KA YOUNG JUNG</last_name>
    <phone>02-550-8276</phone>
  </overall_contact>
  <location>
    <facility>
      <name>SMG-SNU Boramae Medical Center, 41, Borame-Gill, Dong Gjak-Gu</name>
      <address>
        <city>Seoul</city>
        <zip>156-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 17, 2013</lastchanged_date>
  <firstreceived_date>September 16, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Muscle Spasticity</mesh_term>
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>Botulinum Toxins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
